Skip to Content

Onsenal Drug for Polyps Withdrawn from EU - EMA

The European Commission has withdrawn permission for the sale of Onsenal - used to treat intestinal polyps - in the EU, said the European Medicines Agency (EMA).

Pfizer, the manufacturer of the drug, could not prove its safety due to slow enrolment in an ongoing clinical trial. Doubts about its safety could not be dismissed, so Onsenal was banned.

Onsenal was marketed in all EU countries except for Bulgaria, Hungary, Malta, Romania and Slovenia.


Are you optimistic about the new round of reunification talks in Cyprus?
Yes, there's a good opportunity to settle the problem now, the leaders are serious.
No, it's just another waste of everyone's time, the leaders are not serious.
Maybe, let's wait and see.
Total votes: 49